CVS reached a $315 million settlement Tuesday to resolve allegations that it illegally filled prescriptions for opioids and other controlled substances for over a decade and then sought payments for many of those invalid prescriptions from federal healthcare programs.
From October 2013 through December 2025, CVS allegedly knowingly filled prescriptions for controlled substances that lacked a legitimate medical purpose, were not valid, or were not issued in the “usual course of professional practice.”
The settlement resolves a whistleblower lawsuit brought in 2024 that accused the healthcare giant of providing massive amounts of opioids and other controlled substances “to fuel its own profits at the expense of public health and safety.”
People were interested in these podcasts
Corporate policies, poor staffing levels and performance metrics allegedly pressured pharmacists to fill prescriptions without properly checking their medical legitimacy, according to the Justice Department.
The pharmaceutical retailer was accused of dispensing “dangerous and excessive quantities” of opioid prescriptions, including filling them too early, and “trinity” prescriptions, a dangerous drug combination, according to the Justice Department.
CVS also allegedly filled prescriptions from healthcare providers operating as “pill mills” — prescribers that prescribe strong painkillers, such as opioids, without a real medical need.
Pharmacists purportedly filled these prescriptions despite “clear red flags indicating that there was a high likelihood that the prescriptions lacked a legitimate medical purpose, were not valid, or were not issued in the course of professional practice,” according to the Justice Department.
Many of these prescriptions were subsequently billed to and reimbursed by federal healthcare programs, such as Medicare.
CVS also allegedly permitted staffing shortages that “prioritized corporate profits over patient safety,” according to the Justice Department.
The company said it disagrees with the allegations and admits no wrongdoing.
“We have cooperated with the DOJ’s investigation for more than four years, and we strongly disagree with the allegations and false narrative within this complaint,” the CVS Pharmacy spokesperson said in a statement.
The company said that each of the prescriptions in question was for an FDA-approved opioid medication prescribed by a licensed practitioner.
“The government’s lawsuit intensifies a serious dilemma for pharmacists, who are simultaneously second-guessed for dispensing too many opioids and too few,” the statement continued.
Under an agreement with the Drug Enforcement Administration, the company will establish or maintain a Controlled Substance Dispensing Oversight Program, implement a hotline to report suspected illegal dispensing and evaluate suspicious prescribers.
“Today’s settlement requires CVS to implement additional safeguards to ensure that prescriptions for opioids and other controlled substances are dispensed only when medically appropriate,” Assistant Attorney General Brett Shumate of the Justice Department’s Civil Division said in a statement. “The remedial measures in this agreement — including proactive monitoring of opioid prescribing patterns — will provide critical protections for patients and federal healthcare programs.”
This settlement is part of a broader, years-long crackdown by federal, state and local governments to hold major pharmacies, drug wholesalers and manufacturers accountable for their roles in the opioid crisis.
In August, Walmart reached a $50 million settlement with the Justice Department to resolve allegations that its pharmacies knowingly filled invalid prescriptions, let prescribers continue operating as “pill mills” and unlawfully dispensed opioids, fueling the nation’s drug epidemic.
Walmart also entered into a similar agreement with the DEA.
Contact the author
Please read our comment policy before commenting.